Oncology Data Specialist

Aptive

116d•$72,000 - $78,000

About The Position

Cancer Registrar Aptive Resources is seeking a highly qualified Cancer Registrar/Oncology Data Analyst to join our team. The selected candidate shall conduct records maintenance, including submission of complete case abstract and conduct timely case ascertainment and accession to Department of Veterans Affairs (VA) Veterans Health Administration (VHA) approved software. The contractor will conduct data curation and abstraction into VHA approved cancer registry database software. Schedule: Monday–Friday; open to both full-time and part-time availability as long as candidates can attend required meetings during standard business hours. Compensation: • Full-Time: $72,000–$78,000 annually (DOE), with full benefits. • Part-Time: $32–$35/hour (DOE), not to exceed 30 hours per week.

Requirements

3+ years relevant experience
Certified Tumor Registrars (CTR) certification through the National Cancer Registrar's Association (NCRA)
Maintain up-to-date continuing education courses as required for certification. Provide documentation verifying current certification annually.
Completion of all VA educational and mandatory course requirements and any other training as required by the VA by specific due date

Responsibilities

The Contractor shall conduct records maintenance, including submission of complete case abstract and conduct timely case ascertainment and accession to VHA approved software.
The contractor will conduct data curation and abstraction into VHA approved cancer registry database software.
Abstracting shall encompass the full and complete data set (required and VA specific non-North American Association of Central Cancer Registries (NAACCR) supplemental fields) to present a complete patient summary in the VHA approved cancer registry database software. The new database software that is being implemented is KACI.
Text fields shall be utilized to document and substantiate all field values for patient information found in Physical Exam, Scans, Scopes, Labs, TNM and Stage Prognostic Factors, Diagnostic Procedures, Pathology, Treatment, and Surveillance
American Joint Committee on Cancer (AJCC) Tumor-Node-Metastasis (TNM) staging shall be performed on all cases meeting the criteria as established by Surveillance, Epidemiology, and End Results (SEER) and the AJCC, current edition of Staging of Cancer manual, in conjunction with accepted principles.
Meet reporting requirements of state central cancer registry, the American College of Surgeon's Commission on Cancer, and the VA Central Cancer Registry
Maintain patient and records confidentiality in accordance with the Privacy Act of 1974, complying with the terms of VA computer access security agreement, and other applicable government security regulations.
Candidates will complete all applicable “physician TNM staging” fields at the time of case ascertainment and/or case completion.
Provide a list of completed cases to the contact manager.
Provide last vital status, status of disease and substantiating text when reporting incidence and when full data set is completed. Only otherwise updated when patient found to be expired when reporting subsequent primary cancers.
Provide a list to the NOPO Oncology Data Lead noting any deficiencies or non-deficiencies using VA approved trackers at that time.
Tracker will contain at minimum: Facility Identification Number (FIN), Accession/Sequence, Primary Site, Class of Case, Histology/Behavior, Diagnosis Date, Tumor Size, Extent of Disease (EOD), SER Summary State (SSS), AJCC Stage, Treatment Modality Summary, Last follow-up (FU) Date, Personnel Name, and notes detailing errors and corrections made.
VISN/Facility Cancer Committee contact may provide a quality review of this data for validation.
Correct all inconsistencies found through any VACO or hospital quality assurance review within 30 days of notification of inconsistencies, errors, warnings, or any other data quality problems at no additional cost to the Government.
Comply with all guidelines governing the accepted standard of registry operations, to include the Commission on Cancer, AJCC, National Cancer Institute's Surveillance, Epidemiology and End Results Program (SEER), NAACCR, World Health Organization's International Classification of Diseases for Oncology, and all other current and historic manual editions as applicable to diagnosis year.